AMPH vs. SPY
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or SPY.
Correlation
The correlation between AMPH and SPY is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMPH vs. SPY - Performance Comparison
Key characteristics
AMPH:
-0.94
SPY:
2.20
AMPH:
-1.27
SPY:
2.91
AMPH:
0.83
SPY:
1.41
AMPH:
-0.80
SPY:
3.35
AMPH:
-1.61
SPY:
13.99
AMPH:
22.68%
SPY:
2.01%
AMPH:
38.83%
SPY:
12.79%
AMPH:
-49.92%
SPY:
-55.19%
AMPH:
-45.08%
SPY:
-1.35%
Returns By Period
In the year-to-date period, AMPH achieves a -3.85% return, which is significantly lower than SPY's 1.96% return. Over the past 10 years, AMPH has underperformed SPY with an annualized return of 11.77%, while SPY has yielded a comparatively higher 13.29% annualized return.
AMPH
-3.85%
-8.79%
-12.22%
-35.14%
12.34%
11.77%
SPY
1.96%
1.09%
8.43%
25.46%
14.30%
13.29%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. SPY — Risk-Adjusted Performance Rank
AMPH
SPY
AMPH vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMPH vs. SPY - Dividend Comparison
AMPH has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.18%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPDR S&P 500 ETF | 1.18% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
AMPH vs. SPY - Drawdown Comparison
The maximum AMPH drawdown since its inception was -49.92%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for AMPH and SPY. For additional features, visit the drawdowns tool.
Volatility
AMPH vs. SPY - Volatility Comparison
Amphastar Pharmaceuticals, Inc. (AMPH) has a higher volatility of 10.31% compared to SPDR S&P 500 ETF (SPY) at 5.10%. This indicates that AMPH's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.